TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10383LMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $731.70 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10391XMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $846.89 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10401KMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $708.44 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10402LMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $872.09 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10581XMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $846.89 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10588GMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $708.44 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10589HMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $872.09 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
10597RMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $731.70 $31.60 $31.60
space

TRASTUZUMAB

Source General Schedule
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10682FMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 3 $1609.04 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source Section 100 (CT)
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10743KMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 3 $1470.22 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source General Schedule
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10798HMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 0 $1609.04 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source General Schedule
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10803NMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 3 $1609.04 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source Section 100 (CT)
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10811BMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 0 $1470.22 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source Section 100 (CT)
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Medicinal Product Pack
(Name, form & strength and pack size)
Max qty packs Max qty units No. of repeats DPMQ Max Safety Net General Patient Charge
10817HMP TRASTUZUMAB
trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)
1 1 3 $1470.22 $31.60 $31.60
Available brands
Herceptin SC
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
4632TMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
500 mg 0 $468.51 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
4639EMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
250 mg 9 $330.06 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
4650RMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $846.89 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
4703MMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $708.44 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
7264HMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
500 mg 0 $488.42 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
7265JMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
250 mg 9 $348.03 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
7266KMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
1000 mg 0 $872.09 $31.60 $31.60
space

TRASTUZUMAB

Source Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
7267LMP TRASTUZUMAB
Injection (PI, CMI)
Available brands
Herzuma
(trastuzumab 150 mg injection, 1 vial)
Herzuma
(trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack)
Kanjinti
(trastuzumab 150 mg injection, 1 vial)
Kanjinti
(trastuzumab 420 mg injection, 1 vial)
Ogivri
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 150 mg injection, 1 vial)
Trazimera
(trastuzumab 60 mg injection, 1 vial)
750 mg 3 $731.70 $31.60 $31.60
space


  • Legend
  • MPMedical Practitioner